233 related articles for article (PubMed ID: 23328526)
1. Quantifying health services use for chronic obstructive pulmonary disease.
Gershon AS; Guan J; Victor JC; Goldstein R; To T
Am J Respir Crit Care Med; 2013 Mar; 187(6):596-601. PubMed ID: 23328526
[TBL] [Abstract][Full Text] [Related]
2. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
3. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
MMWR Surveill Summ; 2002 Aug; 51(6):1-16. PubMed ID: 12198919
[TBL] [Abstract][Full Text] [Related]
4. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.
Mannino DM; Homa DM; Akinbami LJ; Ford ES; Redd SC
Respir Care; 2002 Oct; 47(10):1184-99. PubMed ID: 12354338
[TBL] [Abstract][Full Text] [Related]
5. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
6. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life.
Goodridge D; Lawson J; Duggleby W; Marciniuk D; Rennie D; Stang M
Respir Med; 2008 Jun; 102(6):885-91. PubMed ID: 18313278
[TBL] [Abstract][Full Text] [Related]
7. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.
Simoni-Wastila L; Yang HW; Blanchette CM; Zhao L; Qian J; Dalal AA
Curr Med Res Opin; 2009 Nov; 25(11):2729-35. PubMed ID: 19778165
[TBL] [Abstract][Full Text] [Related]
8. Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.
Goodridge D; Lawson J; Rennie D; Marciniuk D
Rural Remote Health; 2010; 10(2):1349. PubMed ID: 20438281
[TBL] [Abstract][Full Text] [Related]
9. Forecasting Hospitalization and Emergency Department Visit Rates for Chronic Obstructive Pulmonary Disease. A Time-Series Analysis.
Gershon A; Thiruchelvam D; Moineddin R; Zhao XY; Hwee J; To T
Ann Am Thorac Soc; 2017 Jun; 14(6):867-873. PubMed ID: 28267357
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization and emergency department visits among seniors receiving homecare: a pilot study.
Smith AA; Carusone SB; Willison K; Babineau TJ; Smith SD; Abernathy T; Marrie T; Loeb M
BMC Geriatr; 2005 Jul; 5():9. PubMed ID: 16014173
[TBL] [Abstract][Full Text] [Related]
11. Hospitalizations and return visits after chronic obstructive pulmonary disease ED visits.
Lippmann SJ; Yeatts KB; Waller AE; Hassmiller Lich K; Travers D; Weinberger M; Donohue JF
Am J Emerg Med; 2013 Sep; 31(9):1393-6. PubMed ID: 23910071
[TBL] [Abstract][Full Text] [Related]
12. Changes in COPD demographics and costs over 20 years.
Blanchette CM; Dalal AA; Mapel D
J Med Econ; 2012; 15(6):1176-82. PubMed ID: 22812689
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with frequency of emergency department visits for chronic obstructive pulmonary disease exacerbation.
Tsai CL; Griswold SK; Clark S; Camargo CA
J Gen Intern Med; 2007 Jun; 22(6):799-804. PubMed ID: 17410402
[TBL] [Abstract][Full Text] [Related]
14. Chronic obstructive pulmonary disease and associated health-care resource use - North Carolina, 2007 and 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(8):143-6. PubMed ID: 22377845
[TBL] [Abstract][Full Text] [Related]
15. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
16. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
17. Chronic obstructive lung disease-related health care utilisation in Korean adults with obstructive lung disease.
Jung JY; Kang YA; Park MS; Oh YM; Park EC; Kim HR; Lee SD; Kim SK; Chang J; Kim YS
Int J Tuberc Lung Dis; 2011 Jun; 15(6):824-9. PubMed ID: 21575306
[TBL] [Abstract][Full Text] [Related]
18. Cost and utilization of COPD and asthma among insured adults in the US.
Blanchette CM; Broder M; Ory C; Chang E; Akazawa M; Dalal AA
Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
[TBL] [Abstract][Full Text] [Related]
19. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
